Drug packages protect and deliver prescription and over-the-counter (OTC) drugs, as well as communicating necessary warnings and directions to people, enabling the therapeutic benefit of their contents. Despite the fact that people with disabilities and older adults represent a significant portion of the pharmaceutical market, protocols across the world for testing child-resistant (CR) packaging (ISO, 2003), exclude people with any obvious or overt disabilities from the senior-related portion of the test (Bix et al., 2009) (Figure 9.1). These regulations have a critical impact on the level of inclusivity of commercially available CR packaging currently on the market.
This Research Database has been developed by HCPC Europe to create an overview of the available research in the field of patient-friendly and adherence packaging. The database is for all members of HCPC Europe. Members can register as a user to get access to the database. Is your organisation not a member yet? Then please register your organisation as a member or contact our Executive Director Ger Standhardt for more information.